losartan has been researched along with Schistosomiasis mansoni in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Schistosomiasis mansoni: Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.
Excerpt | Relevance | Reference |
---|---|---|
"Schistosomiasis mansoni is involved in hepatic fibrogenesis and portal hypertension." | 1.48 | The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis. ( Augusto, MJ; Elias Júnior, J; Parreira, NA; Prado, CM; Ramalho, FS; Ramalho, LNZ; Rodrigues, V; Silva, DM, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Parreira, NA | 1 |
Ramalho, FS | 1 |
Augusto, MJ | 1 |
Silva, DM | 1 |
Prado, CM | 1 |
Elias Júnior, J | 1 |
Rodrigues, V | 1 |
Ramalho, LNZ | 1 |
El-Lakkany, NM | 1 |
El-Maadawy, W | 1 |
Ain-Shoka, A | 1 |
Badawy, A | 1 |
Hammam, O | 1 |
Ebeid, F | 1 |
2 other studies available for losartan and Schistosomiasis mansoni
Article | Year |
---|---|
The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; | 2018 |
Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anthelmintics; Disease Models, Animal; Drug Therap | 2011 |